| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers C > Headlines for Cerus Corp. > News item |
Cerus gets $2 million partial payment for commercialization agreement with BioOne
By Ted A. Knutson
Washington, Dec. 1 - Cerus Corp. received a $2 million payment from BioOne Corp. Tuesday as partial payment for the license and related rights in an agreement with BioOne and subsidiaries of Baxter International Inc., the company said in an 8-K filing with the Securities and Exchange Commission.
The agreement involves the commercialization of the Intercept Blood System for plasma in parts of Asia.
Concord, Calif.-based Cerus is a biotech company focusing on blood safety and cancer vaccines.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.